Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was
developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads …

Background: The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the
first implantable defibrillator that avoids placing electrodes in or around the heart. Two large …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to avoid complications related to transvenous implantable cardioverter-defibrillator (TV-ICD) …

Aims To report 5-year outcomes of EFFORTLESS registry patients with early generation
subcutaneous implantable cardioverter-defibrillator (S-ICD) devices. Methods and results …

The subcutaneous implantable cardioverter defibrillator (S-ICD) is a completely
extrathoracic device that has recently been FDA approved for the prevention of sudden …

Aims The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the
conventional transvenous ICD system to minimize intravascular lead complications. There …

Objectives: The purpose of the study was to evaluate the efficacy and safety of the entirely
subcutaneous implantable cardioverter-defibrillator (S-ICD). Background: A new entirely S …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to reduce short-and long-term complications associated with transvenous ICD leads. Early …

Background—The most frequent complications associated with implantable cardioverter-
defibrillators (ICDs) involve the transvenous leads. A subcutaneous implantable cardioverter …

BACKGROUND: The approval of an entirely subcutaneous implantable-cardioverter
defibrillator (ICD) system (S-ICD) has raised attention about this promising technology. It …